Avalo Therapeutics, Inc.
AVTXNasdaqCIK 1534120HealthcareFiscal year ends Dec 31
Reports and events: 313 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0607:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001534120-26-000049 |
| 2026-08-0607:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534120-26-000048 |
| 2026-06-2307:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001534120-26-000044 |
| 2026-06-1607:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-26-000042 |
| 2026-06-1216:06 ET | 8-K | 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001534120-26-000040 |
| 2026-06-0816:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001534120-26-000036 |
| 2026-05-1307:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001534120-26-000033 |
| 2026-05-1307:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534120-26-000032 |
| 2026-05-0719:38 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056482 |
| 2026-05-0516:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-26-000028 |
| 2026-04-2807:01 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001534120-26-000026 |
| 2026-04-1016:01 ET | DEF 14A | Proxy statementPeriod 2026-04-10 | 0001534120-26-000022 |
| 2026-03-2716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001534120-26-000016 |
| 2026-03-2307:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001534120-26-000011 |
| 2026-03-2307:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534120-26-000010 |
| 2026-01-1207:53 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001534120-26-000003 |
| 2025-12-0206:38 ET | 8-K | 8.01 Other events | 0001534120-25-000022 |
| 2025-11-0607:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001534120-25-000018 |
| 2025-11-0607:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001534120-25-000017 |
| 2025-10-2907:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-25-000013 |
| 2025-10-1007:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-25-000011 |
| 2025-10-0107:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001534120-25-000009 |
| 2025-09-2207:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001534120-25-000005 |
| 2025-08-0707:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038575 |
| 2025-08-0707:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038570 |
| 2025-06-2007:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-032232 |
| 2025-06-1807:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-032011 |
| 2025-06-1716:01 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-031818 |
| 2025-06-0516:10 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-029639 |
| 2025-06-0407:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-029225 |
| 2025-05-1207:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-024436 |
| 2025-05-1207:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-024435 |
| 2025-05-0807:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-023442 |
| 2025-05-0107:00 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001628280-25-021311 |
| 2025-03-2607:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-014833 |
| 2025-03-2007:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-013986 |
| 2025-03-2007:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-013984 |
| 2025-01-1307:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-001228 |
| 2025-01-0207:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-000005 |
| 2024-12-0507:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-049979 |
| 2024-11-1207:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-046852 |
| 2024-11-0707:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045965 |
| 2024-11-0707:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045964 |
| 2024-10-0807:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-042478 |
| 2024-09-0907:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-039764 |
| 2024-09-0407:01 ET | 8-K | 8.01 Other events | 0001628280-24-039221 |
| 2024-08-1416:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-037174 |
| 2024-08-1207:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-036591 |
| 2024-08-1207:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-036589 |
| 2024-07-3016:01 ET | 8-K | 8.01 Other events | 0001628280-24-033437 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.